Director Howson to retire from Cue Biopharma board at 2023 annual meeting

Cue Biopharma, Inc.

Ms. Howson informed the board on March 7, 2023 of her retirement.
She will not stand for re-election at the 2023 annual meeting.
Retirement is not due to any disagreement with company operations.
Howson currently serves on Compensation and Governance committees.
No replacement director has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ms. Howson

Director

CUE · Cue Biopharma, Inc.

Filed: March 10, 2023, 6:59 PM ET

On March 7, 2023, Ms. Howson informed the Board of Directors of Cue Biopharma, Inc. (the “Company”) of her intent to retire from the Board of Directors and not stand for re-election at the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Ms. Howson departed as Director at Cue Biopharma, Inc..

Action: retire
Role: Director

Exact text from the filing

On March 7, 2023, Ms. Howson informed the Board of Directors of Cue Biopharma, Inc. (the “Company”) of her intent to retire from the Board of Directors and not stand for re-election at the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”).

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-007304

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.